| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | TBC | 2.80e-03 | 49 | 30 | 2 | SM00164 | |
| Domain | RabGAP-TBC | 3.27e-03 | 53 | 30 | 2 | PF00566 | |
| Domain | TBC_RABGAP | 3.51e-03 | 55 | 30 | 2 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 3.51e-03 | 55 | 30 | 2 | IPR000195 | |
| Domain | Ig_E-set | 1.21e-02 | 104 | 30 | 2 | IPR014756 | |
| Pubmed | 4.96e-04 | 38 | 30 | 2 | 18407958 | ||
| Pubmed | In Vitro Reconstitution and Analysis of SARS-CoV-2/Host Protein-Protein Interactions. | 5.50e-04 | 40 | 30 | 2 | 37483225 | |
| Pubmed | 6.35e-04 | 43 | 30 | 2 | 19077034 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p11 | 1.42e-03 | 85 | 30 | 2 | chr12p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q22 | 3.14e-03 | 127 | 30 | 2 | chr6q22 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.08e-06 | 192 | 30 | 4 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.55e-04 | 156 | 30 | 3 | c380142e49b1e4ecacbf37587aafa57f8562b6ad | |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 157 | 30 | 3 | 554ddbaf83f5d6eb4669c673efdbb28fd87e2ba8 | |
| ToppCell | 343B-Lymphocytic-Plasma_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 157 | 30 | 3 | 2cb3deb5313ce734710c601935ca318e4179077e | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Platelet|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.67e-04 | 160 | 30 | 3 | 768f3cefc3ad4cda229e598cce8bde574cf64bb2 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor | 1.67e-04 | 160 | 30 | 3 | 0cfe130606af433b2aa90e0a20b6c44659dd6fd4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 161 | 30 | 3 | 334f540dff3508d451e5e85e8e4e8f3b8d6b74e7 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 161 | 30 | 3 | 81d44438e4be4e68a59247e62f02026301a8a0c5 | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, Lineage and Cell Type | 1.70e-04 | 161 | 30 | 3 | 8ca34d800551cb0f796293e6bfdcbf58509cc668 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-04 | 162 | 30 | 3 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-04 | 162 | 30 | 3 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | 343B-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-04 | 164 | 30 | 3 | cf62d34ce9dd220fe61748466c84fd70d9ba697c | |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-04 | 164 | 30 | 3 | e00549bc8b3a5566f39031f39d7e698b0b107a7f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-04 | 165 | 30 | 3 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 167 | 30 | 3 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-04 | 172 | 30 | 3 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | critical-Myeloid-pDC|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.10e-04 | 173 | 30 | 3 | e8508c3efbe0f0fae51484a5535d43103c810d4e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.17e-04 | 175 | 30 | 3 | 3b5346fba617292de71963b6175e85a4f182fe30 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.21e-04 | 176 | 30 | 3 | dc4e939a07bad21ab36181f9588df3fa662f9a92 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 2.21e-04 | 176 | 30 | 3 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-04 | 177 | 30 | 3 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 179 | 30 | 3 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 179 | 30 | 3 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.36e-04 | 180 | 30 | 3 | 12f3c4c4aa7fe03c0ef847bd4d4942c808015f5f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.36e-04 | 180 | 30 | 3 | 2a28fbfe10a340c8662c2c8be33792f41fc09088 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.36e-04 | 180 | 30 | 3 | 1bc01bb76d0d3f8db74f9244436d3e6d6015ed5d | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B_plasma|GI_small-bowel / Manually curated celltypes from each tissue | 2.40e-04 | 181 | 30 | 3 | 9b33f531c8ac776706ec7e2d47e95ba30b6ce13c | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-04 | 181 | 30 | 3 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-04 | 181 | 30 | 3 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_small-bowel / Manually curated celltypes from each tissue | 2.40e-04 | 181 | 30 | 3 | a0549a8c2b5b30e91fae3052f398e48baa45d7ff | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-04 | 181 | 30 | 3 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 181 | 30 | 3 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.44e-04 | 182 | 30 | 3 | 204530444e35d4977a7239ac176f477e9e5c29ab | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 183 | 30 | 3 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 183 | 30 | 3 | 824ecda1219fb596a01bf5cfeee29a6daa462098 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 183 | 30 | 3 | 82b84ee065fb573688d59da97a327152a1ba294c | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-04 | 183 | 30 | 3 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | mild_COVID-19-Plasmablast|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.60e-04 | 186 | 30 | 3 | a639d2183b85b1be6e6da2b2e112aec5149d5bcd | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-CLDN10+_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-04 | 186 | 30 | 3 | 56d2f463800d189212ea0acaaf7db09b65a54eb6 | |
| ToppCell | Healthy-multiplets|Healthy / disease group, cell group and cell class | 2.60e-04 | 186 | 30 | 3 | 2ec999b97e95afb898f8083042b0f188d3d234bc | |
| ToppCell | Control-Lymphocyte-B-B_intermediate|Control / Disease, Lineage and Cell Type | 2.64e-04 | 187 | 30 | 3 | 90c9b1a51539838323325f563be4adf5fdf1b38f | |
| ToppCell | E12.5-Epithelial|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.64e-04 | 187 | 30 | 3 | 29ea5e14dac3321df76f6aa4f053068b49c4a4bf | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-04 | 188 | 30 | 3 | c19c89756f2f999e0814f08a89818ef156f6fc69 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.68e-04 | 188 | 30 | 3 | 7499e353ea5853d06558b20cedee3c7910425d7d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-04 | 188 | 30 | 3 | 5707786cc4452dc34f95db2b3cd29f6e025c0622 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.68e-04 | 188 | 30 | 3 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.72e-04 | 189 | 30 | 3 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.72e-04 | 189 | 30 | 3 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | PND10-Epithelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-04 | 189 | 30 | 3 | 89349e226a5512833a94b1bf68056a6985fe4afd | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-04 | 190 | 30 | 3 | 8ff8c586237cf15f930416710bcff45205fe6f70 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.77e-04 | 190 | 30 | 3 | e1b721bb74561fe51c53328a0394c9954e489049 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-04 | 190 | 30 | 3 | 33d1b0a38267270e87702ba5794f07233acf4955 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-04 | 190 | 30 | 3 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-04 | 190 | 30 | 3 | dc20d323cee2741e39fba597263d6418ae0eadaf | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-04 | 190 | 30 | 3 | ec1bd4929dc82bec2c983a31ece4e3aa82f3a2ab | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-04 | 190 | 30 | 3 | ee39fb88f31d2d65b5d3e7416db68f5df07f6637 | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-04 | 190 | 30 | 3 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-04 | 191 | 30 | 3 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-04 | 191 | 30 | 3 | 2f71f1fb6b5872d84860840b22e789a87ab14eec | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-04 | 191 | 30 | 3 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-04 | 191 | 30 | 3 | 4ab3056f9af2a6caed39f32288562f480811cd7b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-04 | 191 | 30 | 3 | 5f8b3b2d38b37027901db9a1cccdbd1ff70f29de | |
| ToppCell | (7)_Epithelial-E_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.81e-04 | 191 | 30 | 3 | 0fc8d109d5c50957ceef5b8b8b818b0c598b1bbe | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-04 | 192 | 30 | 3 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_mem-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.85e-04 | 192 | 30 | 3 | 185dd150d3345cd29625052a46f3ed89f2a9a8f6 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-04 | 192 | 30 | 3 | d6ea34391c3f730684b82e912d9cf55e928b3311 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 193 | 30 | 3 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-04 | 196 | 30 | 3 | ee89f6884aea11aefeaabe043db7f80145dcdf7f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-04 | 196 | 30 | 3 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-04 | 196 | 30 | 3 | e75c36cb042342d69a593fb1ce62fab033889871 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, condition lineage and cell class | 3.08e-04 | 197 | 30 | 3 | 8f35f9741086a38f0e594dce0547b575946f52bb | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.08e-04 | 197 | 30 | 3 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-04 | 198 | 30 | 3 | 96236fa22545f6f4ff3aa8dc002963db8a3468ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-04 | 198 | 30 | 3 | 9e0fdd63069d17430cdc25bf4ffc762afd5e1728 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-04 | 198 | 30 | 3 | 7eb521af938c2609a85d27e2aa7d4317ad6e1e44 | |
| ToppCell | distal-Endothelial-Vein-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.17e-04 | 199 | 30 | 3 | f9fc0482d7ab11f2165b30cce3564b4ff87d61a6 | |
| ToppCell | distal-1-Epithelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.17e-04 | 199 | 30 | 3 | 9086dbb60863c3da2cc5d0a310f28596a01c52ca | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 199 | 30 | 3 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | distal-Endothelial-Vein-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.22e-04 | 200 | 30 | 3 | ff88d28162e0231d5dac0e0c6bec98fa8da58a23 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.22e-04 | 200 | 30 | 3 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | distal-2-Endothelial-Vein|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.22e-04 | 200 | 30 | 3 | 2785225956d2422acab90e99b7debe3709cf3308 | |
| ToppCell | Parenchymal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | 4e5b6cb014d9bcb58e13c7511c86c43e27c496e4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.22e-04 | 200 | 30 | 3 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | distal-Endothelial-Vein|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.22e-04 | 200 | 30 | 3 | 6acf7afe122f81a95c4c66f4d0878d997b57127a | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | 23088edc62bf7d4db890937bfd7925dc316fcc76 | |
| ToppCell | distal-3-Endothelial-Vein|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.22e-04 | 200 | 30 | 3 | 3a5c85bad2e7a9ecf55d90acb04178a343b3f5fd | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.22e-04 | 200 | 30 | 3 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.22e-04 | 200 | 30 | 3 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-04 | 200 | 30 | 3 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | b2d61bc3afac0d78aa30082760da5b1a15d1fad2 | |
| Drug | indoline | 1.83e-05 | 39 | 30 | 3 | CID000010328 | |
| Drug | SYNOVIAL | 3.51e-05 | 7 | 30 | 2 | CID000072095 | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A | 1.15e-04 | 193 | 30 | 4 | 3814_DN | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.15e-04 | 193 | 30 | 4 | 5726_DN | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A | 1.15e-04 | 193 | 30 | 4 | 4240_DN | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.15e-04 | 193 | 30 | 4 | 3850_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 2897_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 1481_UP | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 5111_UP | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 4500_DN | |
| Drug | Crotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 5689_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 1641_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 3618_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 3207_DN | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 5501_DN | |
| Drug | Cefotiam hydrochloride; Up 200; 7.2uM; MCF7; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 5361_UP | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; PC3; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 6726_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.30e-04 | 199 | 30 | 4 | 3541_UP | |
| Drug | ikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 1.30e-04 | 199 | 30 | 4 | 918_DN | |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.30e-04 | 199 | 30 | 4 | 2454_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.30e-04 | 199 | 30 | 4 | 5283_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.32e-04 | 200 | 30 | 4 | 5917_DN | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 1.32e-04 | 200 | 30 | 4 | 4625_DN | |
| Drug | wortmannin; Up 200; 0.01uM; SKMEL5; HG-U133A | 1.32e-04 | 200 | 30 | 4 | 506_UP | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.32e-04 | 200 | 30 | 4 | 7312_UP | |
| Disease | breast cancer, COVID-19 | 2.13e-04 | 22 | 29 | 2 | MONDO_0007254, MONDO_0100096 | |
| Disease | monoclonal gammopathy | 1.25e-03 | 53 | 29 | 2 | EFO_0000203 | |
| Disease | eotaxin measurement | 2.81e-03 | 80 | 29 | 2 | EFO_0008122 | |
| Disease | Mechanical Allodynia | 3.09e-03 | 84 | 29 | 2 | C2936719 | |
| Disease | Hyperalgesia | 3.09e-03 | 84 | 29 | 2 | C0020429 | |
| Disease | Allodynia | 3.09e-03 | 84 | 29 | 2 | C0458247 | |
| Disease | Hyperalgesia, Secondary | 3.09e-03 | 84 | 29 | 2 | C0751212 | |
| Disease | Hyperalgesia, Primary | 3.09e-03 | 84 | 29 | 2 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 3.09e-03 | 84 | 29 | 2 | C0751214 | |
| Disease | Tactile Allodynia | 3.09e-03 | 84 | 29 | 2 | C0751213 | |
| Disease | sodium measurement | 4.61e-03 | 103 | 29 | 2 | EFO_0009282 | |
| Disease | blood urea nitrogen measurement | 9.71e-03 | 452 | 29 | 3 | EFO_0004741 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HHHITERDADRSLTI | 11 | Q8TF27 | |
| LTEQHERVHRLTEHV | 361 | Q96G01 | |
| EESEHSHKHLIELRR | 36 | O14529 | |
| HTVDGIRHVIEIHIV | 126 | P23280 | |
| LRHREHHISELDKEV | 876 | Q8NB25 | |
| EAEIHLHRHKTVIRA | 241 | Q9HD26 | |
| SHRHHVLHDQEVDRR | 671 | Q9ULD0 | |
| HHILHVAVDVIRESR | 441 | P23219 | |
| VRAVHRLLEHRHHSV | 406 | Q8IWF2 | |
| DTVESSLHRHLIEHL | 686 | A2PYH4 | |
| ITLLHVIRIDHTLHE | 46 | Q8NGF1 | |
| ELRSHHILERLDAHI | 671 | Q96MT8 | |
| ENHVRHLHKRVLESE | 66 | Q13617 | |
| HSESRQEHERISRIH | 496 | Q8N4S9 | |
| RHQVHETLLVVEPTH | 216 | A6NIJ5 | |
| HLREQIRREFTLHDH | 176 | P19526 | |
| SQEEHLHHVRQVLVR | 741 | A6NKG5 | |
| EIARQLHHRLSHVDV | 41 | Q9H3E2 | |
| DELVRTHHILIDLRH | 146 | P09758 | |
| HLIEEHRLVREHLLT | 246 | P10155 | |
| HEHSALREHMRLVLE | 241 | O00463 | |
| IIAHRLSTVEHAHLI | 696 | Q9NP78 | |
| CLVVEIRHHHSEHRV | 146 | Q9H7M9 | |
| RAVTIHNTHHLLVER | 2501 | Q86WI1 | |
| ATRREHLVRHVITLH | 271 | Q6AHZ1 | |
| HHTEEITVDHLLVRR | 21 | O43548 | |
| HHLIAEIHTAEIRAT | 61 | P12272 | |
| VSRIDEQVHRHLDQH | 396 | Q8WUA7 | |
| QTSHLIRHKRIHTEE | 176 | Q03924 | |
| RSSEHIHHIDLDVRT | 136 | P35125 | |
| IHHIDLDVRTTLRNH | 141 | P35125 | |
| SHLVIHERTHERERL | 531 | O14978 |